头孢哌酮/舒巴坦治疗下呼吸道感染的疗效观察
Evaluation and Analysis of Drug-Use in Hospitals of China(2006)
Abstract
目的:评价头孢哌酮/舒巴坦(CPZ/SBT)1日1次给药方案治疗下呼吸道感染的合理性。方法:53例下呼吸道感染患者随机分为两组,qd组28例,每日1次静滴CPZ/SBT 4.0g;bid组25例,每日静滴CPZ/SBT 2次,每次2.0g。两组疗程均为7天,以临床疗效和血清杀菌活性(SBA)为观察指标。结果:qd组、bid组临床有效率分别为82.1%、80.0%,无显著性差异(P>0.05);qd组、bid组对所试5种细菌的峰时SBA中位数均为1∶16~1∶32,两组间均无显著性差异(P>0.05)。两组对所试5种细菌峰时SBA≥1:8的百分率,也无显著性差异(P>0.05)。结论:CPZ/SBT日剂量为4.0g时,采用1日1次静滴治疗下呼吸道感染是适宜的,可根据临床具体情况予以选用。
MoreTranslated text
Key words
serum bactericidal activity(SBA),q.d.,clinical effects,rationality,cefoperazone/sulbactam
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined